ARCHIVES

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

This article is from The Cancer Letter archive.

Vol. 07 No. 21 | May 22, 1981

Download PDF Visit The Full Archive

Related Articles

Health Association Oppose U.S. Trade Policy On Tobacco Exports; Recommend Restrictions

August 25, 1989

Griesmer To Leave NTP, Will Return To Oak Ridge

March 28, 1980

CTEP Drafts FDA Approval Guidelines

March 4, 1988

IOM To Advise Army On Spending $210 Mil. Breast Cancer Money

January 8, 1993

Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC

August 10, 2012

NCI’s $65 Million to NTP Will Be Controversial, Untouchable; Spectre Of Another Backlog Looms

February 8, 1980